Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Sabiha Khan is a Rheumatologist in Bethesda, Maryland. Dr. Khan has been practicing medicine for over 17 years and is rated as an Experienced doctor by MediFind in the treatment of Rheumatoid Vasculitis. She is also highly rated in 1 other condition, according to our data. Her top areas of expertise are Eosinophilic Fasciitis, Axial Spondyloarthritis (AxSpA), Ankylosing Spondylitis, and Rheumatoid Pneumoconiosis.
Gineth Pinto-Patarroyo is a Rheumatologist in Manassas, Virginia. Dr. Pinto-Patarroyo has been practicing medicine for over 23 years and is rated as an Experienced doctor by MediFind in the treatment of Rheumatoid Vasculitis. Her top areas of expertise are Ankylosing Spondylitis, Axial Spondyloarthritis (AxSpA), Rheumatoid Lung Disease, and Rheumatoid Pneumoconiosis. Dr. Pinto-Patarroyo is currently accepting new patients.
Michael Greene is an Internal Medicine doctor in Fairfax, Virginia. Dr. Greene has been practicing medicine for over 43 years and is rated as an Experienced doctor by MediFind in the treatment of Rheumatoid Vasculitis. He is also highly rated in 3 other conditions, according to our data. His top areas of expertise are Prekallikrein Deficiency, Congenital Anti-Plasmin Deficiency, Disseminated Intravascular Coagulation, and Axial Spondyloarthritis (AxSpA). Dr. Greene is currently accepting new patients.
Summary: This study was designed to demonstrate the safety and performance of the JOURNEY II XR total knee system by evaluating implant survival rates at 10 years using Kaplan-Meier analysis. All participants will be implanted with the JOURNEY II XR total knee system.
Summary: Hypothesis 1: A reduction in side effects is achieved with monitoring glucocorticoid treatment by using the Glucocorticoid Toxicity Index (GTI) in patients using glucocorticoids. Hypothesis 2: Monitoring treatment by using GTI in patients using glucocorticoids causes a decrease in glucocorticoid toxicity and an increase in the quality of life of patients. Hypothesis 3: With the involvement of the ...